Biotechnology Policy: Overview
I have created a six-hour biotechnology education series at bit.ly/LfbSdS, and I want to highlight the policy discussion here. It is […]
I have created a six-hour biotechnology education series at bit.ly/LfbSdS, and I want to highlight the policy discussion here. It is […]
I have created a six-hour biotechnology education series at bit.ly/LfbSdS, and I want to highlight the policy discussion here. It is
Biotechnology Policy: Balancing Innovation Incentives with Economic Contraints Read Post »
I have created a six-hour biotechnology education series at bit.ly/LfbSdS, and I want to highlight the policy discussion here. It is
On a recent press tour of New Jersey I was introduced to PTC Therapeutics, a fascinating company that is developing
Are Ribosomal Readthrough Drugs the Next Biotech Magic Bullet? Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Seeds, food and trade wars: Public opinion and policy responses in the USA and Europe
Go to paperABSTRACT: The political debate over genetically modified fo…
Seeds, food and trade wars: Public opinion and policy responses in the USA and Europe Read Post »
In the wake of the repositioning of Maryland’s Shady Grove Incubator from biotechnology to cyber security, Virginia has stepped up
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
"Guardian of the Genome" Therapies – A New Golden Age for Cancer R&D? Read Post »
The Journal of Commercial Biotechnology is published by BiotechBlog’s producer, thinkBiotech. Journal of Commercial Biotechnology Volume 20, Number 1 Russia-Focused
Journal of Commercial Biotechnology new issue available Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Mergers and acquisitions: A consideration of the drivers and hurdles
Go to paperABSTRACT: Mergers and acquisitions (M&A) are increasingly being include…
Mergers and acquisitions: A consideration of the drivers and hurdles Read Post »
Get new actionable insights and updates from BiotechBlog